Sanofi (NYSE:SNY)‘s stock had its “buy” rating reaffirmed by analysts at Leerink Swann in a report released on Sunday.
Other analysts have also recently issued research reports about the company. Zacks Investment Research upgraded Sanofi from a “sell” rating to a “hold” rating in a report on Monday, July 25th. Piper Jaffray Cos. initiated coverage on Sanofi in a research note on Friday, September 23rd. They issued a “neutral” rating on the stock. TheStreet raised Sanofi from a “hold” rating to a “buy” rating in a research note on Wednesday, July 27th. Citigroup Inc. reaffirmed a “neutral” rating on shares of Sanofi in a research note on Tuesday, June 28th. Finally, Berenberg Bank raised Sanofi from a “hold” rating to a “buy” rating in a research note on Thursday, September 8th. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $60.50.
Shares of Sanofi (NYSE:SNY) opened at 38.53 on Friday. The stock has a market capitalization of $99.18 billion, a price-to-earnings ratio of 21.36 and a beta of 0.98. The company’s 50 day moving average is $38.79 and its 200-day moving average is $40.45. Sanofi has a 1-year low of $37.41 and a 1-year high of $51.88.
Several institutional investors have recently made changes to their positions in SNY. Bessemer Group Inc. raised its position in shares of Sanofi by 77.1% in the second quarter. Bessemer Group Inc. now owns 3,445 shares of the company’s stock worth $144,000 after buying an additional 1,500 shares during the last quarter. Signaturefd LLC raised its position in shares of Sanofi by 16.4% in the second quarter. Signaturefd LLC now owns 3,480 shares of the company’s stock worth $146,000 after buying an additional 490 shares during the last quarter. JFS Wealth Advisors LLC raised its position in shares of Sanofi by 3.5% in the second quarter. JFS Wealth Advisors LLC now owns 3,961 shares of the company’s stock worth $166,000 after buying an additional 134 shares during the last quarter. BlackRock Institutional Trust Company N.A. acquired a new position in shares of Sanofi during the first quarter worth about $175,000. Finally, Bradley Foster & Sargent Inc. CT acquired a new position in shares of Sanofi during the second quarter worth about $205,000. 9.42% of the stock is currently owned by institutional investors.
Sanofi Company Profile